New Leaf Venture Partners

New Leaf Venture Partners as of June 30, 2016

Portfolio Holdings for New Leaf Venture Partners

New Leaf Venture Partners holds 14 positions in its portfolio as reported in the June 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Edge Therapeutics 20.4 $24M 2.3M 10.11
Versartis 19.4 $23M 2.0M 11.06
Wave Life Sciences (WVE) 14.0 $16M 784k 20.69
Oxford Immunotec Global 10.7 $12M 1.4M 9.00
Dimension Therapeutics 10.6 $12M 2.1M 6.00
Dynavax Technologies (DVAX) 5.7 $6.6M 455k 14.58
Dermira 5.0 $5.7M 197k 29.25
Alder Biopharmaceuticals 4.1 $4.8M 191k 24.97
Sage Therapeutics (SAGE) 4.1 $4.7M 157k 30.13
AVEO Pharmaceuticals 2.1 $2.5M 2.6M 0.96
Karyopharm Therapeutics (KPTI) 1.3 $1.5M 223k 6.71
Vistagen Therapeutics 1.2 $1.4M 353k 3.90
Adaptimmune Therapeutics (ADAP) 0.9 $1.0M 127k 8.15
Trillium Therapeutics, Inc. Cmn 0.6 $725k 81k 8.98